Hospice Deals Heat Up

It’s been a busy year in the Home Health & Hospice sector. Deal volume is poised to surpass the record 85 transactions announced in 2018. Through late November, 79 deals are in our DealSearchOnline database and more are expected before year-end. Home health agencies account for the bulk of the transactions every year, making up […]

 

Health Care M&A Deals, Week Ending November 22, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to […]

 

Lumenis
Lumenis

Lumenis Finally Finds a Buyer

After a four-year partnership, XIO Group has finally sold Lumenis. CVC Capital Partners and FountainVest Partners came incredibly close to purchasing the medical device firm late last year for an estimated $950 million, according to reports in Calcalist, but the deal was never finalized. Fast forward to the present day, and Baring Private Equity Asia […]

 

LGC
LGC

LGC Gets New Owners After Multi-Billion Deal

Cinven and Astorg have joined forces to purchase LGC Group from KKR (NYSE: KKR). The two global private equity firms spent $3.88 billion (£3 billion) for the firm, according to sources cited in Private Equity News. LGC provides a range of measurement tools, proficiency testing schemes, supply chain assurance standards, and specialty genomics reagents to […]

 

U.S. Hospital Deals and Trends, YTD 2019

Winding down to the end of 2019, it’s a good time to take stock of this year’s U.S. hospital M&A market. In mid-November, we have 70 transactions on the books, up 16% compared with the same period in 2018. But 2019 M&A activity has taken a decidedly different path from the deals of 2018. One […]

CRO and CDMO
CRO and CDMO

Phenomics Health Adds Clinical Assessment Capabilities

Making sure patients with multiple chronic conditions aren’t over- or under-dosed with medications can be a fraught process. Phenomics Health, based in Ann Arbor, Michigan, has been working on the genomics side of the problem. Its recent acquisition of Precera Bioscience‘s patented portfolio of pharmacometabolomic technology adds capabilities to provide a more complete view of […]

Health Care M&A Deals, Week Ending November 15, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to […]

Lumenis
Lumenis

PE Firms Trade WIRB-Copernicus for $3 Billion

Leonard Green & Partners, L.P won the auction to acquire WIRB-Copernicus Group (WCG) from Arsenal Capital Partners for $3 billion. The purchase value was originally reported in PE Hub Buyouts. WCG is a clinical services organization that enables biopharmaceutical companies, contract research organizations and institutions to accelerate the delivery of new treatments and therapies to patients. […]

medical office building
medical office building

Welltower Shuffles Medical Office Building Portfolio

Welltower Inc. (NYSE: WELL), one of the largest diversified healthcare REITs, is mixing up its medical office building portfolio. Although Welltower is incredibly active in the Long-Term Care sector with its post-acute care facility portfolio, its MOB portfolio is worth highlighting. So far this year, the company has announced $3.5 billion worth of outpatient medical […]

EyeCare Partners
EyeCare Partners

Biogen Eyes Two Ophthalmic Biosimilars

Boston-based Biogen Inc. (NASDAQ: BIIB) has announced a “proposed transaction” with Samsung Bioepis Co., Ltd. to secure the exclusive rights to commercialize two new ophthalmology biosimilars, SB11 referencing Lucentis® and SB15 referencing Eylea®, in major markets worldwide, including the United States, Canada, Europe, Japan and Australia. In addition, Biogen will acquire exclusive commercialization rights for Samsung […]